Thomas Lofton, chairman of the $10.1 billion Lilly Endowment Inc., Indianapolis, died June 19. He was 86.
Mr. Lofton joined the endowment board as vice chairman in 1991 after retiring from the law firm of Faegre Baker Daniels; he became chairman in 1993 and also was president of the endowment from 1993 to 1994.
The Lilly Endowment was funded through stock grants from the founding family of Eli Lilly & Co. Inc., Indianapolis. The endowment operates independently of the pharmaceutical giant.
The endowment has not named a replacement, said Sallee Roach, assistant to Lilly Endowment President and CEO N. Clay Robbins.
In a statement, the endowment said it was “saddened beyond words” at Mr. Lofton’s death. The statement did not provide further details nor information on services or memorials.
